AGP Picks
View all

The Georgian Health Digest
Provided by AGP

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 5, 2026

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system
Aug. 5, 2026

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

Indeterminate GlobeNewswire
Athelas Launches Practice Manager, the World's First Agentic Practice Management Suite
Aug. 5, 2026

Athelas Launches Practice Manager, the World's First Agentic Practice Management Suite

Indeterminate GlobeNewswire
Pulmera Announces First Clinical Uses of CBeam™ 3D Imaging Platform
Aug. 5, 2026

Pulmera Announces First Clinical Uses of CBeam™ 3D Imaging Platform

Indeterminate GlobeNewswire
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
Aug. 5, 2026

China SXT Pharmaceuticals, Inc. Announces Share Consolidation

Indeterminate GlobeNewswire
Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes
Aug. 5, 2026

Teknova Launches Build-Tek™, a Proprietary AI Reagent Assistant That Allows Customers to Configure Complex Custom Product Requests in Minutes

Indeterminate GlobeNewswire
How Families Can Stay Connected During Back-to-School Chaos
Aug. 5, 2026

How Families Can Stay Connected During Back-to-School Chaos

Indeterminate GlobeNewswire
STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina
Aug. 5, 2026

STERIS To Invest $600 Million to Build a Formulated Chemistries Manufacturing and Distribution Center of Excellence in North Carolina

Indeterminate GlobeNewswire
IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid
Aug. 5, 2026

IAOMT Supports HHS Directive to Phase Out Mercury Dental Fillings in Medicaid

Indeterminate GlobeNewswire
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems
Aug. 5, 2026

BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems

Indeterminate GlobeNewswire
Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026
Aug. 5, 2026

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Indeterminate GlobeNewswire
Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission
Aug. 5, 2026

Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission

Indeterminate GlobeNewswire
Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study
Aug. 5, 2026

Acrivon Advances ACR-2316, a Potential First-in-Class WEE1/PKMYT1 Inhibitor, into Randomized Dose Expansion in its Ongoing Phase 1/2 Study

Indeterminate GlobeNewswire
Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program
Aug. 5, 2026

Propanc Biopharma Completes First Tranche of $5.0 Million Share Repurchase Program

Indeterminate GlobeNewswire
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG
Aug. 5, 2026

Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG

Indeterminate GlobeNewswire
Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway
Aug. 5, 2026

Splash Beverage Group Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® Through FDA Veterinary Pathway

Indeterminate GlobeNewswire
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
Aug. 5, 2026

Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology

Indeterminate GlobeNewswire
Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea
Aug. 5, 2026

Adneuris Therapeutics Grants Exclusive License to Maruishi Pharmaceutical to Advance Cebranopadol in Japan and South Korea

Indeterminate GlobeNewswire
SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome
Aug. 5, 2026

SciSparc: Subsidiary NeuroThera Labs Launches Phase IIb Clinical Trial at Yale Child Study Center for First-of-its-kind Treatment for Tourette Syndrome

Indeterminate GlobeNewswire
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
Aug. 5, 2026

Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026

Indeterminate GlobeNewswire
Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton
Aug. 5, 2026

Lifeward Launches Pilot Program with Ottobock Care to Expand National Access to ReWalk® Personal Exoskeleton

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Georgian Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.